Be Biopharma logo

Be Biopharma

Engineered B cells as medicines

46 employees · est. 2020 · Cambridge, United States

VS
Quentis Therapeutics logo

Quentis Therapeutics

Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer

est. 2016

Quentis Therapeutics is the older company (2020 vs 2016).

Side-by-Side Comparison

Be Biopharma Quentis Therapeutics
Founded
2020 2016 older
Headquarters
Cambridge, United States Not tracked yet
Employees
46 Not tracked yet
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Series C Grant
Total Funding
$356.00M $49.00M
Funding Rounds
4 2
Services
Development of B Cell Medicines, Clinical Trial Management, Preclinical Research in Protein-Based Therapies Not tracked yet
Target Customers
Patients with Hemophilia B, Patients with Hypophosphatasia, Healthcare Providers, Medical Researchers Not tracked yet
Taxonomy
Engineered B Cell Medicines, Hemophilia B Treatment, Genetic Disease Therapies, Cancer Cell Therapy, Biotech Research, Cell Therapies, B Cell Engineering, Biopharmaceuticals, Innovative Therapeutics, Patient-Centric Approach, Cell Therapy Manufacturing, Medical Biotechnology Immuno-therapeutics, ER Stress, Cancer Treatment, Immune System, Cancer Therapy, Innovative Treatments, Biopharmaceuticals, Oncology, Drug Development, Immunotherapy, Cancer Research
Website
be.bio quentistx.com
Be Biopharma logo

About Be Biopharma

Be Biopharma, founded in 2020, is a pioneering player in the Biopharma and Biotechnology sectors. The company's innovative approach is encapsulated in its slogan, "Engineered B cells as medicines," highlighting its commitment to developing novel treatments to significantly enhance patient outcomes....

Quentis Therapeutics logo

About Quentis Therapeutics

Quentis Therapeutics is a biotechnology startup founded in 2016 that is focused on developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer. The company's slogan, "Developing innovative immuno-therapeutics to combat ER stress and empower...

We will tell you when either one moves

BounceWatch watches Be Biopharma and Quentis Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Be Biopharma and Quentis Therapeutics — by email.

Frequently Asked Questions

Be Biopharma — Engineered B cells as medicines. Quentis Therapeutics — Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Be Biopharma has raised $356.00M while Quentis Therapeutics has raised $49.00M.
Be Biopharma and Quentis Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Be Biopharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Be Biopharma on 9 Jun 2026, and Quentis Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes